Jonathan Adelson is a Rheumatologist in Greenbelt, Maryland. Dr. Adelson is rated as a Distinguished provider by MediFind in the treatment of Eosinophilia-Myalgia Syndrome. His top areas of expertise are MASS Phenotype, Mixed Connective Tissue Disease, Eosinophilia-Myalgia Syndrome, and Antisynthetase Syndrome. Dr. Adelson is currently accepting new patients.

Nasser Nasseri-Asl is a Rheumatologist in Catonsville, Maryland. Dr. Nasseri-Asl is rated as a Distinguished provider by MediFind in the treatment of Eosinophilia-Myalgia Syndrome. His top areas of expertise are Eosinophilia-Myalgia Syndrome, Antisynthetase Syndrome, Rheumatoid Arthritis (RA), and Undifferentiated Connective Tissue Disease (UCTD). Dr. Nasseri-Asl is currently accepting new patients.

Yevgeniy Sheyn is a Rheumatologist in Clinton, Maryland. Dr. Sheyn is rated as an Advanced provider by MediFind in the treatment of Eosinophilia-Myalgia Syndrome. His top areas of expertise are Fibromyalgia, Gout, Vitamin D Deficiency, and Tenosynovitis. Dr. Sheyn is currently accepting new patients.

Dr. Christopher-Stine is the Co-Founder and Director of the Johns Hopkins Myositis Center. She is a Professor of Medicine and Neurology. She is a longstanding core faculty member of the Johns Hopkins University School of Medicine College Advisory Program and serves as the Co-Chair of the Johns Hopkins Institutional Review Board (IRB 5). Dr. Christopher-Stine graduated Cum Laude with a B.A. in chemistry from Franklin and Marshall College; was elected to Alpha Omega Alpha at Hahnemann University School of Medicine, where she received her MD degree, and she attained her Masters of Public Health degree from the Johns Hopkins Bloomberg School of Public Health. Her internship and residency training were completed at MCP Hahnemann University, where she also served as Chief Resident. She pursued her rheumatology fellowship training at Johns Hopkins. Dr. Christopher is rated as an Experienced provider by MediFind in the treatment of Eosinophilia-Myalgia Syndrome. Her top areas of expertise are Myositis, Polymyositis, Dermatomyositis, and Inclusion Body Myositis.

Dr. Christopher A. Mecoli is an Associate Professor of Medicine at the Johns Hopkins University School of Medicine. His area of clinical expertise is rheumatology. A physician-scientist, Dr. Mecoli serves on the faculty of Johns Hopkins Myositis Center and Johns Hopkins Scleroderma Center. He earned his M.D. from Rutgers New Jersey Medical School. He completed an internal medicine residency at the Hospital of the University of Pennsylvania and a rheumatology fellowship at Johns Hopkins. He also holds an M.H.S. in clinical investigation from the Johns Hopkins Bloomberg School of Public Health. Dr. Mecoli is rated as an Experienced provider by MediFind in the treatment of Eosinophilia-Myalgia Syndrome. His top areas of expertise are Dermatomyositis, Myositis, Scleroderma, and Polymyositis.

Dr. Ami Shah is an Associate Professor of Medicine and Director of the Division of Rheumatology at the Johns Hopkins University School of Medicine. Dr. Shah also serves as the Co-Director of the Johns Hopkins Scleroderma Center. Her areas of clinical expertise include rheumatology, particularly scleroderma and Raynaud's phenomenon. She is a graduate of the Massachusetts Institute of Technology and Johns Hopkins University School of Medicine. She completed her internal medicine residency training at Stanford University Hospital & Clinics and rheumatology post-doctoral fellowship at Johns Hopkins. During her fellowship training, she earned her Master of Health Science in Clinical Investigation at the Johns Hopkins Bloomberg School of Public Health. Dr. Shah’s clinical practice is focused on the broad spectrum of patients with scleroderma and related disorders, and her expertise includes management of complications such as Raynaud’s phenomenon, digital ischemia, pulmonary hypertension, cardiac dysfunction, myopathy, aggressive skin disease and concomitant cancer. Dr. Shah teaches post-doctoral fellows in her clinic about the evaluation and management of scleroderma. Dr. Shah’s research program has focused on the interface between cancer and autoimmunity in scleroderma, myositis and the newly emerging area of immune-related adverse events due to immune checkpoint inhibitor therapy. In highly collaborative studies, her group has published seminal observations linking cancer with the development of autoimmunity in scleroderma, with implications for cancer screening strategies in this population and the potential to shed insight into the pathogenesis of paraneoplastic rheumatic disease. In addition to her work in cancer and autoimmunity, Dr. Shah has an active research program in other clinical and therapeutic aspects of scleroderma, including early detection of cardiopulmonary complications and improving outcome measures and therapeutics for Raynaud's phenomenon. Dr. Shah also directs rheumatology precision medicine initiatives through the Johns Hopkins Individualized Health (inHealth) Initiative. The division’s program seeks to harness technological resources for comprehensive data collection and harmonization, strengthen novel data analytic approaches including defining unique patient subgroups, and accelerate the incorporation of discoveries into the delivery of clinical care. Dr. Shah has been a recipient of the ACR Research and Education Foundation Clinical Investigator Fellowship Award. In 2018, her research contributions were recognized at the 5th Systemic Sclerosis World Congress with receipt of the Edith Busch Prize for Young Investigators. In 2020, she was honored to receive the prestigious Henry Kunkel Young Investigator Award from the American College of Rheumatology. She is a member of the American College of Rheumatology. Dr. Shah is rated as an Experienced provider by MediFind in the treatment of Eosinophilia-Myalgia Syndrome. Her top areas of expertise are Scleroderma, Scleroma, Systemic Sclerosis (SSc), and Scleredema.

Laura Hummers is an Associate Professor of Medicine in the Division of Rheumatology. She graduated from the University of Rochester School of Medicine and trained in internal medicine at Thomas Jefferson University. She then pursued her rheumatology fellowship at Johns Hopkins University and has since been on the faculty working at the Johns Hopkins Scleroderma Center since 2003 where she has been Co-Director of the Center. She received her ScM degree through the Graduate Training Program in Clinical Investigation from the Bloomberg School of Public Health in 2010. Dr. Hummers also serves as Clinical Director for the Division of Rheumatology. Dr. Hummers actively participates in a number of clinical trials and clinical investigations at the Scleroderma Center and has a particular interest in predictors of outcomes in scleroderma. She actively manages a large patient practice focused exclusively on scleroderma and related conditions at Johns Hopkins and actively helps to manage the Johns Hopkins Scleroderma Center longitudinal database. She also has specific expertise in other scleroderma-like conditions such as scleromyxedema, scleredema and eosinophilic fasciitis. Dr. Hummers is rated as an Experienced provider by MediFind in the treatment of Eosinophilia-Myalgia Syndrome. Her top areas of expertise are Scleroderma, Systemic Sclerosis (SSc), Eosinophilic Fasciitis, and Scleroma.

Dr. Alan Baer graduated from the Johns Hopkins University School of Medicine in 1978 and completed his post-graduate medical training in Internal Medicine and Rheumatology at the Johns Hopkins and Vanderbilt University Hospitals. He was a faculty member at the University at Buffalo, State University of New York, from 1986 to 2007, and served there as Chief of the Section of Rheumatology and Fellowship Program Director. He joined the faculty at Johns Hopkins in 2007 and is currently Professor of Medicine and Director of the Jerome L. Greene Sjogren's Syndrome Center. Since 2015, he has been an Investigator in the Sjogren's Syndrome Clinic at the National Institutes of Health. He was Chief of Rheumatology and Clinical Director of the Johns Hopkins University Rheumatology Practice at the Good Samaritan Hospital in Baltimore, Maryland from 2007 to 2014. Dr. Baer is currently engaged in a number of research studies in the area of Sjogren's syndrome, both at Johns Hopkins and in the NIH Sjogren's Syndrome Clinic. He was the principal investigator of the NIH subcontract to Johns Hopkins to conduct the Sjogren's International Registry (SICCA) and enrolled 300 patients into the registry. The SICCA registry has been a rich source of clinical data and biospecimens for research that Dr. Baer is conducting with colleagues at both Hopkins and the University of California-San Francisco. He is conducting a longitudinal observational study of patients with Sjogren's syndrome. Dr. Baer is rated as an Experienced provider by MediFind in the treatment of Eosinophilia-Myalgia Syndrome. His top areas of expertise are Sjogren Syndrome, Rheumatoid Arthritis (RA), Arthritis, and Interstitial Keratitis.

Dr. Albayda is an Associate Professor of Medicine in the Division of Rheumatology. She is the Director of the Rheumatology Fellowship Program, as well as Director of the Musculoskeletal Ultrasound and Injection Clinic. Nationally, she is involved in MSK Ultrasound education and has expertise in arthritis and inflammatory myopathies. Her research focuses on imaging biomarkers in rheumatic diseases, developing muscle ultrasound, clinical phenotypes in myositis, as well as longitudinal care and therapeutics in inclusion body myositis. Dr. Albayda is rated as an Experienced provider by MediFind in the treatment of Eosinophilia-Myalgia Syndrome. Her top areas of expertise are Dermatomyositis, Pallister-Killian Mosaic Syndrome, Temple Syndrome, and Inclusion Body Myositis.

Donald Thomas is a Rheumatologist in Greenbelt, Maryland. Dr. Thomas is rated as an Experienced provider by MediFind in the treatment of Eosinophilia-Myalgia Syndrome. His top areas of expertise are Sjogren Syndrome, Rheumatoid Arthritis (RA), Postmenopausal Osteoporosis, and Osteoporosis. Dr. Thomas is currently accepting new patients.

Anjana Dhar is a primary care provider, practicing in Internal Medicine in Silver Spring,, Maryland. Dr. Dhar is rated as an Experienced provider by MediFind in the treatment of Eosinophilia-Myalgia Syndrome. Her top areas of expertise are Eosinophilia-Myalgia Syndrome, Antisynthetase Syndrome, High Cholesterol, and MASS Phenotype.

Rukmini Konatalapalli is a Rheumatologist in Greenbelt, Maryland. Dr. Konatalapalli is rated as an Experienced provider by MediFind in the treatment of Eosinophilia-Myalgia Syndrome. Her top areas of expertise are Gout, Fibromyalgia, Rheumatoid Arthritis (RA), and Bursitis. Dr. Konatalapalli is currently accepting new patients.

Seema Patel is a Rheumatologist in Baltimore, Maryland. Dr. Patel has been practicing medicine for over 18 years and is rated as an Experienced provider by MediFind in the treatment of Eosinophilia-Myalgia Syndrome. Her top areas of expertise are Fibromyalgia, Raynaud Phenomenon, Rheumatoid Arthritis (RA), and Discoid Lupus Erythematosus (DLE).

Seyed Forghani-Saeidabadi is a Rheumatologist in Catonsville, Maryland. Dr. Forghani-Saeidabadi is rated as an Advanced provider by MediFind in the treatment of Eosinophilia-Myalgia Syndrome. His top areas of expertise are Antisynthetase Syndrome, Eosinophilia-Myalgia Syndrome, Undifferentiated Connective Tissue Disease (UCTD), and Rheumatoid Arthritis (RA). Dr. Forghani-Saeidabadi is currently accepting new patients.

Ebrahim Talebi-Quje is a Rheumatologist and a Geriatrics provider in Catonsville, Maryland. Dr. Talebi-Quje is rated as an Advanced provider by MediFind in the treatment of Eosinophilia-Myalgia Syndrome. His top areas of expertise are Eosinophilia-Myalgia Syndrome, Antisynthetase Syndrome, Fibromyalgia, and Rheumatoid Arthritis (RA). Dr. Talebi-Quje is currently accepting new patients.

Paneez Khoury is a primary care provider, practicing in Internal Medicine in Bethesda, Maryland. Dr. Khoury is rated as an Advanced provider by MediFind in the treatment of Eosinophilia-Myalgia Syndrome. Her top areas of expertise are Hypereosinophilic Syndrome, Granulomatosis with Polyangiitis, Esophagitis, Eosinophilic Esophagitis, and Tissue Biopsy.

Iago Pinal-Fernandez is a primary care provider, practicing in Internal Medicine in Bethesda, Maryland. Dr. Pinal-Fernandez is rated as an Advanced provider by MediFind in the treatment of Eosinophilia-Myalgia Syndrome. His top areas of expertise are Myositis, Polymyositis, Dermatomyositis, Antisynthetase Syndrome, and Lung Transplant.

Paul Gertler is a Rheumatologist in Ellicott City, Maryland. Dr. Gertler is rated as an Advanced provider by MediFind in the treatment of Eosinophilia-Myalgia Syndrome. His top areas of expertise are Eosinophilia-Myalgia Syndrome, Antisynthetase Syndrome, Rheumatoid Arthritis (RA), and Psoriatic Arthritis.

Ariel Warden-Jarrett is a primary care provider, practicing in Family Medicine in Columbia, Maryland. Dr. Warden-Jarrett has been practicing medicine for over 18 years and is rated as an Experienced provider by MediFind in the treatment of Eosinophilia-Myalgia Syndrome. Her top areas of expertise are Salivary Duct Stones, Antisynthetase Syndrome, Eosinophilia-Myalgia Syndrome, and Mixed Connective Tissue Disease. Dr. Warden-Jarrett is currently accepting new patients.

Dr. Wigley received his M.D. degree from the University of Florida College of Medicine. He completed an internship and residency at Johns Hopkins where he also trained in a postdoctoral fellowship program. Dr. Wigley is a physician-scientist whose specialty is Raynaud’s phenomenon and scleroderma. He founded The Johns Hopkins Scleroderma Center with Robert A. Wise, M.D., of the Johns Hopkins Division of Pulmonary Medicine. Dr. Wigley has been honored with two American College of Rheumatology awards over the past couple years. He received the ACR Distinguished Clinician Scholar Award in 2009 and the ACR Masters Award in 2011. Dr. Wigley is rated as an Experienced provider by MediFind in the treatment of Eosinophilia-Myalgia Syndrome. His top areas of expertise are Scleroderma, Systemic Sclerosis (SSc), Raynaud Phenomenon, and Scleroma.